During the past decade, Legacy Health System conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Legacy Health System" #1 sponsor was "Actelion" with 4 trials, followed by "Legacy Health System" with 3 trials sponsored, "American Burn Association" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Foresee Pharmaceuticals Co., Ltd." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Legacy Health System" #1 collaborator was "Oregon Health and Science University" with 2 trials as a collaborator, "Children's Hospital Los Angeles" with 1 trials as a collaborator, "DUSA Pharmaceuticals, Inc." with 1 trials as a collaborator, "Hackensack Meridian Health" with 1 trials as a collaborator and "Hospital for Special Surgery, New York" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Legacy Health System" are "Pulmonary Arterial Hypertension" (3 trials), "Anticoagulants" (1 trials), "Autism Spectrum Disorder" (1 trials), "Breast Cancer" (1 trials) and "Burn Injury" (1 trials). Many other conditions were trialed in "Legacy Health System" in a lesser frequency.

Most popular intervention types in "Legacy Health System" are "Drug" (12 trials), "Behavioral" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5-Aminolevuline Acid" (1 trials), "AASPIRE Healthcare Toolkit" (1 trials), "Albumin Human" (1 trials) and "Bivalirudin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Legacy Health System" are 17 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Legacy Health System". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Legacy Health System, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Legacy Health System, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".